Zdrowie i gospodarka · 25/07/2024

FDA Releases Final Guidance on Using Electronic Health Records and Medical Claims Data for Drug and Biological Product Regulation

The US Food and Drug Administration (FDA) has released a final guidance document outlining considerations for using electronic health records and medical claims data to support regulatory decisions on drug and biological products, as part of its Real-World Evidence (RWE) program.